Reinhardt Medical is proud to be the exclusive representative for Nikkiso dialysis products in Canada.

The Nikkiso DBB-EXA with its proprietary one-touch D-FAS system is transforming dialysis therapy for Nephrology programs and patients globally. Together, Reinhardt Medical and Nikkiso are revolutionizing the in-centre hemodialysis market in Canada with the Nikkiso DBB-EXA. The Nikkiso DBB-EXA is an ultra reliable, user friendly, machine, with D-FAS technology.  

The Dialysis Fully Automated System (D-FAS) automates several processes, enabling your clinicians to focus on the most important task – patient care. The D-FAS system decreases the number of nursing interactions with the DBB-EXA leading to a reduced potential for errors.

D-FAS technology standardizes operational tasks enabling work flow optimization by:

    • Providing one-touch automated saline or online priming capabilities.

    • Automatic wash back without user intervention.

    • Allows one-touch blood filling with or without ultrafiltration (UF) during priming.

    • Includes a one-touch emergency button with automatic minimum UF and optional bolus.

    • Automated minimum UF based on user defined limits.


DBB-EXA Overview

Automation

The DBB-EXA provides more time for patient care by reducing routine treatment tasks.

1

Advanced Monitoring and Flexible Treatment Options

On-line HD, HDF, HF, ISO-UF, SNDP, and SNSP treatment options and BVM, Haemo Master, DDM, DIP, and iNIBP monitoring options, come standard on the DBB-EXA.

2

Innovative Design and Reliability

With its 15 inch colour touchscreen monitor, the DBB-EXA is intuitive, compact, easy to maneuver, and lightweight (90kg). Providing industry leading mean time between failure (MTBF) of 3,500 hours.

3

Cost Effective and Environmentally Responsible

The DBB-EXA with its standard functionalities allows for online capabilities, provides a reduction in consumables and biomedical waste. Thereby, reducing the DBB-EXA’s carbon footprint.

4